Original language | English (US) |
---|---|
Pages (from-to) | 766-769 |
Number of pages | 4 |
Journal | Heart Rhythm |
Volume | 20 |
Issue number | 5 |
DOIs | |
State | Published - May 2023 |
Bibliographical note
Funding Information:Funding Sources: The authors have no funding sources to disclose. Disclosures: Dr Berul’s laboratory received research support from Medtronic, Inc., External Research Program. All other authors have no conflicts of interest to disclose.
Funding Information:
Thank you to the engineers and leadership at Medtronic for bringing this pediatric pacemaker to fruition, even without a clear market incentive from a business standpoint. We appreciate the parents of the babies who consented to placement of an investigational device under Emergency Use from the Food and Drug Administration under the Expanded Access medical device pathway. Thank you to the dedicated teams of cardiac surgeons, nurses, cardiologists, neonatologists, maternal–fetal medicine obstetricians, anesthesiologists, and others in coordinating care for the smallest of babies requiring urgent early pacing. Thank you to Sofia Hanaberg for designing the graphical abstract. Funding Sources: The authors have no funding sources to disclose. Disclosures: Dr Berul's laboratory received research support from Medtronic, Inc., External Research Program. All other authors have no conflicts of interest to disclose.
Keywords
- Congenital
- Epicardial pacing
- Novel device therapy
- Pacemaker
- Pediatric
PubMed: MeSH publication types
- Journal Article